17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception

British Journal of Pharmacology

Volumn 165, Issue 3, 2012, Pages 683-692

  Bang, S ^a   Yoo, S ^a   Yang, T J ^a   Cho, H ^b   Hwang, S ^a  

^a Korea University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

17(R) resolvin D1; inflammation; keratinocytes; nociceptive behaviours; pain; specific inhibitor; TRPV3

Indexed keywords

RESOLVIN D1; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 3; VANILLOID RECEPTOR ANTAGONIST;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; INHIBITION KINETICS; KERATINOCYTE; LICKING; MALE; MOUSE; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; CAPSAICIN; CARRAGEENAN; CELL LINE; DOCOSAHEXAENOIC ACIDS; FREUND'S ADJUVANT; GANGLIA, SPINAL; HEK293 CELLS; HOT TEMPERATURE; HUMANS; INFLAMMATION; KERATINOCYTES; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SENSORY RECEPTOR CELLS; TRPV CATION CHANNELS;

EID: 84855679839     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01568.x     Document Type: Article

References (46)

1. Alexander SP, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edition. Br J Pharmacol 153 (Suppl. 1): S1-S324.
2. Andersson DA, Gentry C, Moss S, Bevan S, (2008). Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci 28: 2485-2494. (Pubitemid 351348185)
3. Ariel A, Serhan CN, (2007). Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28: 176-183. (Pubitemid 46467520)
4. Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ, et al,. (2004). Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41: 849-857. (Pubitemid 38429729)
5. Bang S, Kim KY, Yoo S, Kim YG, Hwang SW, (2007a). Transient receptor potential A1 mediates acetaldehyde-evoked pain sensation. Eur J Neurosci 26: 2516-2523. (Pubitemid 350050447)
6. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW, (2007b). Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425: 120-125. (Pubitemid 47410367)
7. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2010a). Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3. J Biol Chem 285: 19362-19371.
8. Bang S, Yoo S, Yang TJ, Cho H, Kim YG, Hwang SW, (2010b). Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br J Pharmacol 161: 707-720.
9. Bang S, Yoo S, Oh U, Hwang SW, (2010c). Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation. Arch Pharm Res 33: 1509-1520.
10. Bang S, Yoo S, Yang TJ, Cho H, Hwang SW, (2011). Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain 152: 1156-1164.
11. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI, et al,. (2001). Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 411: 957-962. (Pubitemid 32601493)
12. Grant AD, Cottrell GS, Amadesi S, Trevisani M, Nicoletti P, Materazzi S, et al,. (2007). Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 578: 715-733. (Pubitemid 46165505)
13. Gullapalli STA, Lingam PR, Kattige V, Gudi GS, Khairatkar-Joshi N, (2008). GRC 15133-A Novel, Selective TRPV3 Antagonist with Anti-Hyperalgesic Effects in Inflammatory and Neuropathic Pain. CHI-World Pharmaceutical Congress: Philadelphia, PA.
14. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX, (2001). The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21: 7463-7473. (Pubitemid 32904945)
15. Hu HZ, Xiao R, Wang C, Gao N, Colton CK, Wood JD, et al,. (2006). Potentiation of TRPV3 channel function by unsaturated fatty acids. J Cell Physiol 208: 201-212. (Pubitemid 43849006)
16. Hu H, Grandl J, Bandell M, Petrus M, Patapoutian A, (2009). Two amino acid residues determine 2-APB sensitivity of the ion channels TRPV3 and TRPV4. Proc Natl Acad Sci USA 106: 1626-1631.
17. Huang SM, Lee H, Chung MK, Park U, Yu YY, Bradshaw HB, et al,. (2008). Overexpressed transient receptor potential vanilloid 3 ion channels in skin keratinocytes modulate pain sensitivity via prostaglandin E2. J Neurosci 28: 13727-13737.
18. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, et al,. (2000). Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 97: 6155-6160. (Pubitemid 30367539)
19. Kim KY, Bang S, Han S, Nguyen YH, Kang TM, Kang KW, et al,. (2008). TRP-independent inhibition of the phospholipase C pathway by natural sensory ligands. Biochem Biophys Res Commun 370: 295-300.
20. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, et al,. (2010). Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 107: 1660-1665.
21. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN, (2001). Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612-619. (Pubitemid 32677628)
22. Lima-Garcia J, Dutra R, da Silva K, Motta E, Campos M, Calixto J, (2011). The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 164: 278-293.
23. Liu B, Linley JE, Du X, Zhang X, Ooi L, Zhang H, et al,. (2010). The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl- channels. J Clin Invest 120: 1240-1252.
24. McKemy DD, Neuhausser WM, Julius D, (2002). Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature 416: 52-58. (Pubitemid 34215395)
25. Mandadi S, Sokabe T, Shibasaki K, Katanosaka K, Mizuno A, Moqrich A, et al,. (2009). TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Arch 458: 1093-1102.
26. Moqrich A, Hwang SW, Earley TJ, Petrus MJ, Murray AN, Spencer KS, et al,. (2005). Impaired thermosensation in mice lacking TRPV3, a heat and camphor sensor in the skin. Science 307: 1468-1472. (Pubitemid 40321945)
27. Moran MM, Wei DS, Zhen X, Mandel-Brehm J, Witek J, Yaksh T, et al,. (2007). Potent and selective antagonists validate TRPV3 as a target for analgesic therapeutics. In: Society of Neuroscience Annual Meeting pp 2007 2143.2005/J2006. San Diego.
28. Patapoutian A, Tate S, Woolf CJ, (2009). Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 8: 55-68.
29. Patwardhan AM, Scotland PE, Akopian AN, Hargreaves KM, (2009). Activation of TRPV1 in the spinal cord by oxidized linoleic acid metabolites contributes to inflammatory hyperalgesia. Proc Natl Acad Sci USA 106: 18820-18824.
30. Peier AM, Reeve AJ, Andersson DA, Moqrich A, Earley TJ, Hergarden AC, et al,. (2002). A heat-sensitive TRP channel expressed in keratinocytes. Science 296: 2046-2049. (Pubitemid 34627531)
31. Petrus M, Peier AM, Bandell M, Hwang SW, Huynh T, Olney N, et al,. (2007). A role of TRPA1 in mechanical hyperalgesia is revealed by pharmacological inhibition. Mol Pain 3: 40.
32. Puntambekar P, Van Buren J, Raisinghani M, Premkumar LS, Ramkumar V, (2004). Direct interaction of adenosine with the TRPV1 channel protein. J Neurosci 24: 3663-3671. (Pubitemid 38481124)
33. Ryu JJ, Yoo S, Kim KY, Park JS, Bang S, Lee SH, et al,. (2010). Laser-modulation of heat and capsaicin receptor TRPV1 leads to thermal antinociception. J Dent Res 89: 1455-1460.
34. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, et al,. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J Exp Med 196: 1025-1037. (Pubitemid 35231761)
35. Shin J, Cho H, Hwang SW, Jung J, Shin CY, Lee SY, et al,. (2002). Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc Natl Acad Sci USA 99: 10150-10155. (Pubitemid 34831187)
36. Stone TW, (1993). Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309-379. (Pubitemid 23292874)
37. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al,. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829. (Pubitemid 36378884)
38. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, et al,. (2007). Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 282: 9323-9334. (Pubitemid 47104612)
39. Taylor-Clark TE, Undem BJ, Macglashan DW Jr, Ghatta S, Carr MJ, McAlexander MA, (2008). Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential A1 (TRPA1). Mol Pharmacol 73: 274-281. (Pubitemid 351159199)
40. Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, et al,. (2008). N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3- hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 326: 432-442.
41. Tominaga M, Caterina MJ, Malmberg AB, Rosen TA, Gilbert H, Skinner K, et al,. (1998). The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21: 531-543. (Pubitemid 28475505)
42. Vincent F, Acevedo A, Nguyen MT, Dourado M, DeFalco J, Gustafson A, et al,. (2009). Identification and characterization of novel TRPV4 modulators. Biochem Biophys Res Commun 389: 490-494.
43. Vogt-Eisele AK, Weber K, Sherkheli MA, Vielhaber G, Panten J, Gisselmann G, et al,. (2007). Monoterpenoid agonists of TRPV3. Br J Pharmacol 151: 530-540. (Pubitemid 46905006)
44. Vriens J, Appendino G, Nilius B, (2009). Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 75: 1262-1279.
45. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B, (2003). Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438. (Pubitemid 36917492)
46. Xu ZZ, Zhang L, Liu T, Park JY, Berta T, Yang R, et al,. (2010). Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. Nat Med 16: 592-597.